Responses were similar among patients with estrogen patches and ARPIs compared to luteinizing hormone releasing hormone ...

Nutriband and Kindeva formalize exclusive product development partnership and long-term commitment based on shared development costs in exchange for milestone payments Nutriband is partnering with ...

Aversa Fentanyl holds the potential to become the world’s first abuse-deterrent opioid patch.

A mid-stage study reveals that transdermal estradiol patches may match traditional androgen deprivation therapy in treating prostate cancer with fewer side effects. This approach boosts bone density ...

Prostate-specific antigen responses were similar between transdermal estradiol and hormone therapy combined with androgen receptor inhibitors in prostate cancer.

With 90% of the U.S. population living within 10 miles of a Walmart store, recalls of products they sell can have widespread ...

When prostate cancer patients need therapy to reduce male hormone levels, delivering some of the treatment via a patch on the skin may be just as effective as traditional means of administration with ...

However, with transdermal systems ... the results demonstrate little or no increased VTE risk with initial patch use compared with initial pill use. Most importantly, all of these studies have ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

Transdermal contraceptive patches provide a more convenient delivery system for combined hormonal birth control than daily oral contraceptives. Clinical trials demonstrate that greater numbers of ...

Nutriband Inc. (the “Company”)(NASDAQ:NTRB)(NASDAQ:NTRBW), a developer of transdermal pharmaceutical products, today announced World and European Wrestling Gold medalist and Olympic Silver medalist ...

ORLANDO - Nutriband Inc. (NASDAQ:NTRB), a developer of transdermal pharmaceutical products, has announced an exclusive partnership with Kindeva Drug Delivery to develop Aversa™ Fentanyl, a potential ...